Artiva Biotherapeutics, Inc. Common Stock (NASDAQ: ARTV) last traded at $6.77, down 2.45% on the session. The quote above updates while this page is open; the figures below are drawn from Artiva Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Artiva Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker ARTV. Its market capitalisation is $330.99 million.
Valuation measures for Artiva Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $330.99M |
|---|---|
| Enterprise value | $50.66M |
| Price / book | 0.95 |
| Beta | 2.06 |
Trailing-twelve-month figures tagged in Artiva Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$90.82M |
|---|
| Return on equity | -26.14% |
|---|
| Cash | $301.45M |
|---|
Range and volume for ARTV over the past 52 weeks.
| 52-week high | $14.53 |
|---|---|
| 52-week low | $2.71 |
| Volume | 248.5K |
| Average volume | 398.6K |
| Previous close | $6.94 |
Invest a chosen dollar amount in Artiva Biotherapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ARTV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.